Latest Observability News

Citigroup Global Markets Australia has announced a fully franked dividend for RIO CitiFirst Self-Funding Instalments, with dividend proceeds directed to reduce outstanding loan amounts. The record and ex-dividend dates align with those of RIO ordinary shares.

Mount Ridley Mines Limited has validated its heavy rare earth element resource through historical metallurgical testwork showing recoveries up to 86.5% across the Grass Patch Complex. The results underpin ongoing development efforts and metallurgical optimisation plans.

Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals has broadened availability of DAYBUE STIX, a new FDA-approved powder formulation of trofinetide for Rett syndrome, in the US. Early caregiver feedback and expert consensus highlight its potential role in personalised patient care.

Aguia Resources’ Brazilian subsidiary has achieved a key regulatory milestone with official fertiliser registration, enabling commercial sales of its PAMPAFOS phosphate product in Brazil’s large agricultural market.

Torque Metals Limited (ASX: TOR) reports significant new high-grade gold intercepts from recent drilling at its Paris Gold Project in Western Australia, extending mineralisation up to 500 metres beyond the current Mineral Resource Estimate. The company plans an interim resource update in Q2 2026 amid ongoing multi-rig drilling.

Radiopharm Theranostics has received a positive recommendation to escalate the dose of its 177Lu-RAD202 radiotherapeutic in a Phase 1 trial targeting HER2-positive advanced solid tumors, maintaining its timeline to complete dose escalation by year-end 2026.

PolarX Limited has reported exceptional high-grade copper assay results from its 2025 drilling at the Caribou Dome Copper Project in Alaska, with plans for a substantial 10,500m drilling campaign commencing in June 2026.

Saturn Metals Limited has announced exceptional high-grade gold assay results from its Apollo Hill Gold Project in Western Australia, including a record 1m intercept grading 277g/t Au. These findings highlight significant untapped northern extensions beyond the existing 2.24Moz Mineral Resource and support ongoing exploration and resource growth.

Vitrafy Life Sciences has announced the completion of Phase II testing of a platelet cryopreservation study with the U.S. Army Institute of Surgical Research, showing consistent results for the legacy wash-based protocol and encouraging outcomes for an innovative no-wash approach.

Regis Resources reported a strong cash and bullion increase of $198 million in the March 2026 quarter, lifting its balance to $1.128 billion despite gold production trailing FY26 guidance. The company continues to monitor fuel supply risks amid national uncertainties.

Talonx Resources (ASX: TXR) has commenced a 3,000-metre Reverse Circulation drilling program targeting high-grade gold mineralisation at its Blair North and Viking projects in Western Australia, with assay results expected from Blair North in May 2026.

Sparc Technologies Limited (ASX: SPN) attributes its recent share price increase and trading volume surge to Managing Director Nick O’Loughlin’s participation in a widely listened-to podcast, confirming no undisclosed material information and compliance with ASX Listing Rules.